Precigen Inc. (PGEN)
1.39
0.02 (1.46%)
At close: Apr 17, 2025, 3:59 PM
1.44
3.60%
After-hours: Apr 17, 2025, 07:59 PM EDT
Precigen Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exemplar Segment Revenue | 953K | 717K | 1.38M | 1.77M | 1.85M | 1.65M | 2.1M | 2.84M | n/a | n/a | n/a | n/a |
| Exemplar Segment Revenue Growth | +32.91% | -48.01% | -21.96% | -4.54% | +12.39% | -21.50% | -26.15% | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 233K | 530K | 595K | 1.4M | 11.95M | 17.61M | 11.97M | 5.92M |
| Non-Us Revenue Growth | -56.04% | -10.92% | -57.53% | -88.27% | -32.15% | +47.09% | +102.25% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.84M | 10.31M | 9.35M | 9.06M | 10.14M | 9.32M | 11.64M | 11.51M | 10.14M | 12.67M | 19.58M | 16.76M | 18.66M | 20M | 18.7M | 30.04M | 22.3M | 18.74M | 23.02M | 28.36M | 24.74M | 21.48M | 33.59M | 24.93M | 38.71M | 34.43M | 39.74M | 32.84M | 39.28M | 38.84M | 35.14M | 35.36M | 33.81M | 30.26M | 42.88M | 34.74M | 23.02M | 23.67M | 27.63M |
| Selling, General, and Administrative Revenue Growth | -4.56% | +10.18% | +3.29% | -10.66% | +8.81% | -19.96% | +1.12% | +13.54% | -19.99% | -35.28% | +16.78% | -10.17% | -6.69% | +6.92% | -37.74% | +34.70% | +19.00% | -18.59% | -18.83% | +14.62% | +15.17% | -36.05% | +34.73% | -35.58% | +12.44% | -13.36% | +20.98% | -16.38% | +1.12% | +10.54% | -0.63% | +4.58% | +11.73% | -29.43% | +23.44% | +50.91% | -2.76% | -14.32% | n/a |
| Research and Development Revenue | 11.37M | 15.69M | 14.25M | 12.99M | 12.62M | 11.87M | 12.16M | 10.79M | 12.62M | 11.95M | 12.76M | 13.02M | 12.92M | 13.68M | 10.52M | 10.67M | 12.15M | 14.21M | 18.89M | 21.04M | 31.48M | 34.52M | 33.06M | 280.51M | 44.88M | 42.05M | 37.27M | 38.54M | 36.47M | 34.01M | 34.18M | 29.02M | 29.04M | 28.38M | 25.86M | 26.2M | 21.6M | 20.38M | 79.31M |
| Research and Development Revenue Growth | -27.55% | +10.13% | +9.66% | +2.95% | +6.30% | -2.38% | +12.69% | -14.49% | +5.59% | -6.32% | -1.99% | +0.77% | -5.56% | +30.04% | -1.41% | -12.20% | -14.46% | -24.79% | -10.19% | -33.18% | -8.80% | +4.40% | -88.21% | +524.96% | +6.74% | +12.83% | -3.31% | +5.68% | +7.24% | -0.49% | +17.78% | -0.05% | +2.33% | +9.74% | -1.30% | +21.29% | +5.97% | -74.30% | n/a |